Comparative Uptake of Tc-99m Sestamibi and Tc-99m Tetrofosmin in Cancer Cells and Tissue Expressing P-Glycoprotein or Multidrug Resistance Associated Protein
![]() |
Cho, Jung-Ah
(Department of Nuclear Medicine, School of Medicine, Kyungpook National University)
Lee, Jae-Tae (Department of Nuclear Medicine, School of Medicine, Kyungpook National University) Yoo, Jung-Ah (Department of Nuclear Medicine, School of Medicine, Kyungpook National University) Seo, Ji-Hyoung (Department of Nuclear Medicine, School of Medicine, Kyungpook National University) Bae, Jin-Ho (Department of Nuclear Medicine, School of Medicine, Kyungpook National University) Jeong, Shin-Young (Department of Nuclear Medicine, School of Medicine, Kyungpook National University) Ahn, Byeong-Cheol (Department of Nuclear Medicine, School of Medicine, Kyungpook National University) Sohn, Sang-Gyun (Department of Internal Medicine, School of Medicine, Kyungpook National University) Ha, Jeoung-Hee (Department of Pharmacology, School of Medicine, Kyungpook National University) Lee, Kyu-Bo (Department of Nuclear Medicine, School of Medicine, Kyungpook National University) |
1 | Kao CH, Ho YJ, Shen YY, Lee JK. Evaluation of chemotheraphy response in patients with small cell lung cancer using technetium-99m-tetrofosmin. Anticancer Res 1999;19:2311-5 PUBMED |
2 | Choi SU, Kim NY, Choi EJ, Kim KH, Lee CO. Establishment of doxorubicin-resistant subline derived from HCT15 human colorectal cancer cells. Arch Pharm Res 1996;19:342-7 DOI ScienceOn |
3 | Kim JK, Lee J, Lee BH, Choi SW, Yoo SE, Lee SW, et al. Reversal of multidrug resistance with KR-30035: evaluated with biodistribution of Tc-99m MIBI in nude mice bearing human tumor xenografts. Korean J Nucl Med 2001;35:168-84 |
4 | Piwnica-Worms D, Rao VV, Krounage JF, Croop JM. Characterization of multidrug resistance transport function with an organotechnetium cation. Biochemistry 1995;34:12210-20 DOI ScienceOn |
5 | Arbab AS, Koizumi K, Toyama K, Araki T. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. J Nucl Med 1996;37:1551-6 PUBMED |
6 | Gottesman MM, Pastan I. Biochemistry of multidrug-resistance mediated by the multidrug transporter. Annu Rev Biochem 1993;62:385-427 DOI ScienceOn |
7 | Breuninger LM, Paul S, Gaughan K, Miki T, Chan A, Aaronson SA. Expression of multidrug resistance associated protein with increased drug efflux and altered intracellular drug distribution. Cancer Res 1995;55:5342-7 PUBMED |
8 | Narasaki F, Oka M, Nakano R, Ikeda K, Fukuda M, Nakamura T, et al. Human canalicular multispecific organic anion transporter (cMOAT) is expressed in human lung, gastric, and colorectal cancer cell. Biochem Biophys Res Commun 1997;240:606-11 DOI ScienceOn |
9 | Dole LA, Ross DD. Multidrug resistance mediated by breast cancer resistance protein BCRP(ABCG2). Oncogene 2003;20:7340-58 |
10 | Webb M, Brun M, McNiven M, Le-Couteur D, Craft P. MDR1 and MRP expression in chronic B-cell lymphoproliferative disorders. Br J Haematol 1998;102:710-7 DOI ScienceOn |
11 | Lee J, Ahn BC. Detection of multidrug resistance using molecular nuclear technique. Korean J Nucl Med 2004;38:180-9 |
12 |
Rodrigues M, Chehne F, Kalinowaka W, Zielinski C, Sinzinger H. Comparative |
13 | Piwnica-Worms D, Holman BL. Noncardiac applications of hexakis (alkylisonitrile) technetium-99m complexes. J Nucl Med 1990;31:1166-7 PUBMED |
14 | Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, et al. Overexpression of a transporter gene in a multidrugresistance human lung cancer cell line. Science 1992;258:1650-4 DOI PUBMED |
15 |
Rodrigues M, Chehne F, Kalinowska W, Berghammer P, Zielinki C, Sinzinger H. Uptake of |
16 | Perek N, Prevot N, Koumanov F, Frere D, Sabido O, Beauchesne P, et al. Involvement of the glutathione S-conjugate compounds and the MRP protein in Tc-99m-tetrofosmin and Tc-99m-sestamibi uptake in glioma cell lines. Nucl Med Biol 2000;27:299-307 DOI ScienceOn |
17 | Sharma V. Radiopharmaceuticals for assessment of multidrug resistance p-glycoprotein-mediated drug transport activity. Bioconjug Chem 2004;15:1464-74 DOI PUBMED ScienceOn |
18 | Palmedo H, Schomburg A, Grunwald F, Mallmann P, Boldt I, Biersack HJ. Scintimammography with Tc-99m MIBI in patients with suspicion of primary breast cancer. Nucl Med Biol 1996;23: 681-4 DOI ScienceOn |
19 | Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM. Functional imaging of multidrug-resistance P-glycoprotein with an organotechnetium complex. Cancer Res 1993;53:977-84 PUBMED |
20 | Ballinger JR, Banneman J, Boxen I, Firby P, Hartman NG, Moore MJ. Tc-99m-tetrofosmin as a substrate for P-glycoprotein: In vitro studies in multidrug-resistance breast tumor cells. J Nucl Med 1996;37:1578-82 |
21 |
Bernard BF, Krenning EP, Breeman WA, Ensing G, Benjamins H, Bakker WH, et al. |
22 | Cordobes MD, Starzec A, Delmon-Moingeon L, Blanchot C, Kouyoumdjian JC, Prevost G, et al. Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression. J Nucl Med 1996;37:286-9 PUBMED |
23 |
Yoo JA, Chung SY, Seo MR, Kwak DS, Ahn BC, Lee KB et al. Comparison of the uptake in |
24 | Arbab AS, Koizumi K, Toyama K, Arai T, Araki T. Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells. J Nucl Med 1998;39:266-71 |
25 | Yoo JA, Jeong SY, Seo MR, Bae JH, Ahn BC, Lee KB, et al. Comparison of the uptake of Tc-99m MIBI and Tc-99m tetrofosmin in A549, and MRP-expressing cancer cells, in vitro and in vivo. Korean J Nucl Med 2003;37:382-92 |
26 | Hendrikse NH, Franssen EJ, van-der-Graaf WT, Vaalsburg W, de-Vries EG. Visualization of multidrug resistance in vivo. Eur J Nucl Med 1999;26:283-93 DOI ScienceOn |
27 | Utsunomiya K, Ballinger JR, Piquette-Miller M, Rauth AM, Tang W, Su ZF, et al. Comparison of the accumulation and efflux kinetics of technetium-99m seestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell line. Eur J Nucl Med 2000;27:1786-92 DOI ScienceOn |
28 |
Kinuya S, Yokoyama K, Li XF, Bai J, Watanabe N, Shuke N, et al. Hypoxia-induced alteration of tracer accumulation in cultured cancer cells and xenografts in mice: implication for pre-therapeutic prediction of treatment outcomes with |
29 | Evers R, Zaman GJR, van Deemter L, Jansen H, Calafat J, Oomen LCJM, et al. Basolateral localization and export activity of the human multidrug resistance-associated protein (MRP) in polarized pig kidney cells. J Clin Invest 1996;97:1211-8 DOI |
30 | Delmon-Moigeon LI, Piwnica-Worms D, Van den Abbeele AD, Holman BL, Davison A, Jones AG. Uptake of the cation hexakis -(2-methoxyisobutylisonitrile)-Technetium-99m by human carcinoma cell lines in vitro. Cancer Res 1990;50:2198-201 PUBMED |
31 | Bradley G, Juranka PF, Ling V. Mechanism of multidrug-resitance. Biochim Biophys Acta 1988;948:87-128 PUBMED |
32 |
Chun KA, Lee J, Lee SW, Kang DY, Sohn SK, Lee JK, et al. Effect of multidrug resistance gene-1 (mdr1) overexpression on in - vitro uptake of |
33 | Kao CH, Tsai SC, Wang JJ, Ho YJ, Ho ST, Changlai SP. Technetium-99m-sestamethoxyisobutylisonitrile scan as a predictor of chemotherapy response in malignant lymphoma compared with P-glycoprotein expression, multidrug resistance-related protein expression and other factors. Br J Hematol 2001;113;369-74 DOI ScienceOn |
34 |
Ding HJ, Shiau YC, Tsai SC, Wang JJ, Ho ST, Kao A. Uptake of |
35 | Buscombe JR, Cwikla JB, Thakrar DS, Hilson AJ. Uptake of Tc-99m MIBI related to tumour size and type. Anticancer Res 1997;17:1693-4 PUBMED |
36 |
Papantoniou V, Christodoulidou J, Papadaki E, Valotassiou V, Souvatzoglou M, Louvrou A, et al. Uptake and washout of |
![]() |